Simpler Grants.gov #HT942526LCRPIDA

Defense Health Agency Solicits Innovative Lung Cancer Research Proposals for FY26 Idea Development Award

The Defense Health Agency, through its Research and Development and Contracting Activity offices, is soliciting innovative research proposals for the FY26 Lung Cancer Research Program (LCRP) Idea Development Award (IDA). - Government Buyer: - Defense Health Agency (DHA) - Defense Health Agency Research and Development (DHA R&D) - Defense Health Agency Contracting Activity (DHACA) - Products/Services Requested: - High-risk/high-reward research projects focused on lung cancer (excluding mesothelioma) - Approximately eight awards anticipated, each with a maximum funding cap of $800,000 - Maximum period of performance per award is 3 years - Includes a New Investigator category for early-career faculty and an Established Investigator category - Research must address at least one FY26 LCRP Area of Emphasis and demonstrate relevance to military health, Veterans, and their families - Unique/Notable Requirements: - Open to both extramural and intramural U.S. Department of War organizations - Preliminary data required to support research feasibility, but does not need to be derived from lung cancer studies - Submission through Grants.gov, with active SAM.gov and eBRAP.org registrations required - Awards funded with FY26 funds, expiring no later than September 30, 2032, and made by September 30, 2027 - No specific OEMs or commercial vendors are mentioned, as this is a research grant opportunity rather than a procurement of products or services.

Description

The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Idea Development Award (IDA) supports conceptually innovative, high-risk/high-reward research aimed at accelerating progress toward eradicating deaths and suffering from lung cancer. This funding opportunity promotes new ideas in early stages of development with potential for impactful data and new research avenues. It includes a New Investigator category for early faculty applicants to compete separately from established investigators. The total funding available is approximately $6.4 million to support about eight awards, each with a maximum cost cap of $800,000 and a maximum performance period of 3 years. Applications must address at least one of the FY26 LCRP areas of emphasis.

View original listing